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Abstract
Background: The increasing emphasis on research, development and innovation for health in providing solutions
to the high burden of diseases in the African Region has warranted a proliferation of studies including clinical trials.
This changing public health landscape requires that countries develop adequate ethics review capacities to protect
and minimize risks to study participants. Therefore, this study assessed the readiness of national ethics committees
to respond to challenges posed by a globalized biomedical research system which is constantly challenged by new
public health threats, rapid scientific and technological advancements affecting biomedical research and development,
delivery and manufacture of vaccines and therapies, and health technology transfer.
Methods: This is a descriptive study, which used a questionnaire structured to elicit information on the existence of
relevant national legal frameworks, mechanisms for ethical review; as well as capacity requirements for national ethics
committees. The questionnaire was available in English and French and was sent to 41 of the then 46 Member States
of the WHO African Region, excluding the five Lusophone Member States. Information was gathered from senior
officials in ministries of health, who by virtue of their offices were considered to have expert knowledge of research
ethics review systems in their respective countries.
Results: Thirty three of the 41 countries (80.5 %) responded. Thirty (90.9 %) of respondent countries had a national
ethics review committee (NEC); 79 % of which were established by law. Twenty-five (83.3 %) NECs had secretarial and
administrative support. Over 50 % of countries with NECs indicated a need for capacity strengthening through periodic
training on international guidelines for health research (including clinical trials) ethics; and allocation of funds for
administrative and secretariat support.
Conclusions: Despite the existing training initiatives, the Region still experiences a shortage of professionals trained in
health research ethics/ethicists. Committees continue to face various capacity needs especially for evaluating clinical
trials, for monitoring ongoing research, database management and for accrediting institutional ethics committees.
Given the growing number of clinical trials involving human participants in the African Region, there is urgent need for
supporting countries without NECs to establish them; capacity strengthening where they exist; and creation of a
regional network and joint ethical review mechanisms, whose membership would be open to all NECs of the Region.
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Background
All research on humans should be conducted in accord-
ance with basic ethical principles of respect for persons,
beneficence and justice. It is the duty of Ethics Review
Committees (ERCs), whether national or institutional, to
review and approve proposals that demonstrate this
standard [1]. In 2001 the 51st session of the WHO
Regional Committee for Africa expressed concerns
about some health-related studies undertaken in the
Region which had not been subjected to any form of
ethics review [2]. Following this, a rapid survey of na-
tional ethics review committees (NECs) was conducted
in 2003 in 28 countries of the WHO African Region.
The survey revealed that 36 % of these countries did not
have ERCs, 15 % indicated that ethical approval of re-
search proposals was not required [3].
A similar study conducted in 2008 revealed that regula-
tory infrastructures and independent oversight processes
that could minimize the risk of exploitation were not-so-
firmly established; NECs were inadequately supported
financially and could not maintain and sustain themselves;
they were faced with operational challenges stemming
from a dearth of trained bioethicists/ethicists and/or ad-
equately experienced committee members skilled enough
to undertake ethics review [4, 5]. This raises concerns as
to whether research ethics principles can be adequately
enforced in these countries. There is need for identifying
gaps and strengthening capacities of countries to respond
to a globalized biomedical research system which is
constantly challenged by new public health threats, rapid
scientific and technological advancements affecting bio-
medical research and development (R&D), delivery and
manufacture of vaccines and therapies.
Ministers of health of countries in WHO African
Region endorsed the Algiers Declaration and committed
themselves to, among others [6]:
 establish or strengthen governance structures to
promote ethics and increase public trust in research;
 establish appropriate mechanisms for scientific and
ethical oversight of research for health, including
regulation of clinical trials and sensitization of the
people to their role, their rights and their obligations
in research for health;
 develop a critical mass of focal persons and
well-trained national researchers, including those
working abroad, in various disciplines and areas of
health research, including ethics and regulation; and to
 establish norms and standards, including ethical
ones, taking into account technological progress and
new knowledge management methods.
This provides a rich backdrop for investigating how
well-equipped national ethics committees in countries of
the WHO African Region are to safeguard the dignity,
rights and safety of research participants in the current
public health landscape. This study was conducted in
2012 to assess the readiness of NECs to provide ad-
equate ethical oversight on health research conducted in
countries; and to identify areas for capacity strengthen-
ing. Readiness of NECs was assessed against their imple-
mentation of the following three inter-dependent themes
described below.
a. Governance of health research ethics
International guidelines such as the Declaration of
Helsinki [7], the Council for International Organization of
Medical Sciences (CIOMS) international ethical guidelines
[1, 8], the International Conference on Harmonization of
Good Clinical Practice (ICH-GCP) guidelines [9], and
WHO’s standards and operational guidance for ethics
review [10], provide ethical standards for conducting
health research involving human participants. While these
international guidelines provide a sound operational
framework for governing ethical research, they are not
enforceable in most countries of the African Region since
they do not have the force of law. It therefore becomes
necessary for countries to adopt these standards, taking
into account their unique national health research needs
and contexts, into a form that can be enforced by law. A
legally binding framework, as has been argued by Chima
[11] would provide a measure of protection for research
participants.
b. Existence of mechanisms for ethical review of health
research
National Ethics Committees have the responsibility for
safeguarding the dignity, rights and safety of research
participants in their respective countries. This respon-
sibility is not only accomplished through the ethical re-
view and approval of health research proposals. It is a
responsibility with a longer life-span requiring NECs to
continuously monitor and evaluate health research,
through reports and site visits, to ensure compliance
with ethical standards and with the approved research
protocol [12].
c. Continuous ethics training and capacity
requirements
To be able to perform its functions, a NEC needs to
have the requisite ethics review competencies/capacities
among its members and the necessary administrative
and logistical support. The ethics review competencies
can be acquired through formal training or through
“learning by doing”. The Committee should therefore
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have some members formally trained in ethics, while en-
suring a balanced representation of disciplines, interest
groups and even gender. Continuous ethics training and
capacity building opportunities should be availed to all
members of the Committee to ensure that they stay
abreast with new developments in the field. The import-
ance of permanent and reliable secretarial, administra-
tive and logistical support for the smooth functioning of
a NEC cannot be gainsaid.
Methods
The readiness and capacities of NECs to cope with the
current global ethical review requirement was assessed
by including questions addressing the three themes
mentioned above. Table 1 below provides a summary of
sample questions that were asked in the survey under
each theme.
To assess governance of health research ethics, the
survey questionnaire elicited information regarding the
existence of law/policy for the creation of NECs, in-
cluding a provision establishing ethical standards for
research involving human participants, and whether
reference is made to any regional or international guide-
lines for medical research. Other questions elicited infor-
mation on clear provision for NEC membership criteria;
composition and functions of NECs; and whether all re-
search institutions were required to adopt policy regard-
ing research ethics.
As concerns the existence of mechanisms for ethical re-
view of health research proposals, the questionnaire elic-
ited information on the existence of NECs with standard
operating procedures (SOPs) including clear guidelines for
decision-making and managing scenarios of conflict of
interest. The questionnaire also elicited information on
mechanisms for monitoring on-going research; and
penalties for non-compliance with ethical standards. The
questions for this section used open-ended questions such
as “Are there penalties for non-compliance with the regula-
tions or decisions of the national ethics committee?” and “If
so, what are the penalties?” which allowed survey respon-
dents to provide specific details of their respective country
contexts. (More examples provided on Table 1 below).
To determine provision for continuous ethics training
and capacity strengthening the questionnaire elicited
information on training requirements for NEC members;
and the availability of opportunities for capacity
strengthening for committee members. An inquiry was
made on whether NECs were familiar with a number of
key international guidelines and declarations (Helsinki,
CIOMS, WHO, Nuremberg code) as a proxy to assess
the level of basic knowledge and awareness of inter-
national health research ethics by committee members.
A number of questions on the availability of permanent
and reliable secretarial, administrative and logistical
capacities for the smooth-running of NECs were in-
cluded in the questionnaire. In order to allow for key
capacity needs to emerge from the survey, the following
Table 1 Sample questions on survey questionnaire
Theme 1: Existence of national framework for governing ethical review
• Is there a law/policy establishing a national ethics committee?
• What are the main functions of the national ethics committee?
• Are there written guidelines for constituting (i.e. selecting members)
the national ethics committee?
• What year was the first national ethics committee established?
• Is there a policy/law in your country that establishes the applicable
ethical standards for research involving human subjects?
• Are regional or international guidelines referred to in the national
laws?
• Are all health research institutions in your country required to adopt a
policy regarding research ethics?
Theme 2: Existence of mechanisms for ethical review
• Does the national ethics committee have standard operating
procedures to guide its work?
• If some members of the committee disagree with the majority’s
decision, is the substance of the disagreement recorded and
communicated?
• Is there an explicit mechanism for excluding committee members with
a direct interest in a proposal for review from participating in its
assessment?
• Are there penalties for non-compliance with the regulations and
decisions of the national ethics committee?
- If so, what are the penalties?
• Are there mechanisms in place for monitoring ongoing research?
• What types of mechanisms are applied for monitoring ongoing
research?
- Annual ethical review of previously approved projects
- Required periodic written report from principal investigator
- Unannounced audit of research by representatives of ethical review
committee
- Other
Theme 3: Continuous ethics training and capacity requirements
• Is training/capacity building opportunities provided to members of the
national ethics committee?
• Is this training required or optional for members of the ethics
committee?
• Is the ethics committee familiar with the following: CIOMS guidelines,
WHO guidelines, declaration of Helsinki, Nuremberg Code?
• Does the committee engage the services of consultants from time to
time for technical support?
• Is there any secretarial and administrative support for the national
ethics committee?
• What in your view are the specific capacity needs of the national
ethics committee?
• What in your opinion could be done to improve the performance of
the national ethics committee?
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two-open ended questions were asked at the end of the
questionnaire:
 What in your view are the specific capacity needs of
the national ethics committee?
 What in your opinion can be done to improve the
performance of the national ethics committee?
The survey questionnaire was developed in English
and was externally reviewed by experts in the field to en-
sure relevance and coherence. It was then translated into
French and was sent to ministries of health through the
offices of WHO Representatives in the 20 Anglophone
and 21 Francophone countries respectively. The ques-
tionnaire was not translated into Portuguese and was
therefore not administered to the 5 Lusophone countries
in the Region. The targeted respondents were senior
officials in the ministry of health, who by virtue of their
offices were considered to have expert knowledge of
the research ethics review system in their respective
countries.
Limitations of the survey
The questionnaire was sent to 41 out of the 47 countries
of the WHO African Region. The five Portuguese speak-
ing countries were omitted, and thus the results might
not be generalizable to Portuguese speaking countries.
South Sudan was also not included in the survey since it
was not among Member States of the African Region at
the time.
Secondly, the types of questions asked by this survey
mainly focused on the role of NECs as reviewers and
approvers of research proposals and with a focus on
their role in monitoring the process of research. The
survey failed to enquire on the role played by NECs in
ensuring dissemination of research findings to stake-
holders and ensuring equitable risk-benefit-sharing of
research with the communities involved.
Finally, the findings of this study suggest that NECs in
the Region, by virtue of age, can be presumed to have
attained an appreciable level of maturity and experience.
The study does not provide an analysis to confirm oper-
ational independence and maturity of NECs, which can
be drawn for example from the experiences of commit-
tee members, exposure to different genres of research
proposals, studies of different disease types and commu-
nities, and complex vis-à-vis simple study designs. Such
an analysis would provide a better understanding of
NEC maturity beyond what can be inferred by virtue of
old age.
Ethics clearance
The WHO Regional Office for Africa Ethics Review
Committee reviewed and provided approval for the
study reported in this paper. The preamble to the
questionnaire indicated that the aim of this survey was
to gain a better understanding of the operations, as well
as the legal and institutional frameworks supporting
National Ethics Review Committees in African Countries.
It also explained that the study would not have any direct
benefits for individuals participating in the survey, and
that the findings would be used for planning WHO sup-
port to countries for strengthening their NECs. The re-
spondents were informed of their right to consent or not
to consent to participating in the survey; and that there
would be no consequences if one chose not to participate.
Results and discussion
Thirty-three (33) out of a possible 41 countries (80.5 %)
responded to the questionnaire. About 90 % of Anglophone
countries responded compared to 71.4 % of Francophone
countries. About 66.7 % respondents identified themselves
as being members of NECs. Table 2 below summarizes
the basic characteristics of NECs in responding countries
highlighting findings on the existence of NECs and their
respective dates of formation; countries in which NECs
are created by legislation; the existence of law/policy
establishing ethical standards for review of health research
proposals; and those with secretarial and administrative
support dedicated to NEC operations.
The survey shows that 31 of respondent countries
(93.9 %) had NECs at the time of the survey. The pattern
of establishment of NECs in the Region indicates three
main waves. The first wave of early starters comprises of
Zimbabwe whose NEC is the oldest in the Region and was
created in 1974. The other early starters are The Gambia
and Nigeria whose NECs were both created in 1980. The
second wave comprises of NECs which were created
between 1981 and 1999 and with an average age of
18.3 years. The NECs in the second wave include those of
Algeria, Botswana, Ethiopia, Guinea, Madagascar, Niger,
Seychelles, Sierra Leone, and Uganda. More than half of
the NECs (54.5 %) were formed after the year 2000, which
is the third wave coinciding with a number of significant
global events such as the biotechnology revolution and
the onset of the biopharmaceutical industry, the proli-
feration into the continent of HIV clinical trials and the
human genome project. The NECs in the third wave have
an average age of 8.9 years and include Benin, Burkina Faso,
Burundi, Central African Republic, Congo, Democratic
Republic of Congo, Eritrea, Gabon, Ghana, Kenya, Lesotho,
Liberia, Mali, Senegal, South Africa, Swaziland, Tanzania,
and Zambia.
These findings show that majority of countries in the
Region have established NECs. Equatorial Guinea which
at the time of the survey did not have a NEC established
one in 2013. This leaves Chad as the only country, among
those that participated in this study and according to the
Motari et al. BMC Medical Ethics  (2015) 16:82 Page 4 of 9
best of our knowledge, which does not have a NEC in
place. It is also clear that NECs in the Region, except that
of Equatorial Guinea, have been in existence for some
time implying a certain level of maturity, accumulated
experience, and operational independence [13].
a. Governance of health research ethics
About 74.2 % of the responding countries had NECs
established by either law or policy, and as expected all
these countries except Kenya and Lesotho, indicated that
they had guidance on the applicable ethical standards
for reviewing health research proposals. A further ana-
lysis of the survey responses shows that most countries
indicated that their NECs are established and governed
by the application of policy instruments. These policies
are most often instruments of interpreting provisions
found in National Health Research or Public Health stat-
utes. This could potentially create a legislative loophole
on the authority and autonomy of NECs, which can be
easily exploited to the detriment of the protection of re-
search participants.
Table 2 Overview of basic characteristics of NECs in the African Region






NEC has secretarial and
administrative support
Algeria Yes (1990) Yes Yes Yes
Benin Yes (2007) Yes Yes Yes
Botswana Yes (1984) Yes Yes Yes
Burkina Faso Yes (2002) Yes Yes Yes
Burundi Yes (2006) No response Yes No
CAR Yes (2005) Nil Nil No
Chad Nil N/A N/A N/A
Congo Yes (2007) Nil Nil No
DRC Yes (2003) Nil Nil Yes
Eritrea Yes (2006) No response Yes No
Ethiopia Yes (1995) Yes Yes Yes
Equatorial Guinea Nil N/A N/A N/A
Gambia Yes (1980) Yes Nil Yes
Gabon Yes (2007) Nil Nil Yes
Ghana Yes (2002) Yes Yes Yes
Guinea Yes (1999) Yes Yes Yes
Kenya Yes (2009) Yes No response Yes
Lesotho Yes (2007) Yes Nil Yes
Liberia Yes (2006) Yes Yes Yes
Madagascar Yes (1994) Nil Yes Yes
Malawi Yes Yes Yes Yes
Mali Yes (2002) Yes Yes Yes
Niger Yes (1999) Yes Yes No
Nigeria Yes (1980) Yes Yes Yes
Senegal Yes (2001) Yes Yes Yes
Seychelles Yes (1991) (law enacted in 2012) Yes No response
Sierra Leone Yes (1993) Yes Yes Yes
South Africa Yes (2006) Yes Yes Yes
Swaziland Yes (2006) Yes Yes Yes
Tanzania Yes (2002) Yes Yes Yes
Uganda Yes (1995) Yes Yes Yes
Zambia Yes (2008) Yes Yes Yes
Zimbabwe Yes (1974) Yes Yes Yes
Motari et al. BMC Medical Ethics  (2015) 16:82 Page 5 of 9
All respondent countries indicated that they refer-
enced international guidelines for ethical research in
their operations. The commonly cited international
guidelines were the Helsinki Declaration, CIOMS guide-
lines [1, 8], WHO guidelines [10, 12], and the Belmont
report [14]. All countries except Liberia, Niger and
Nigeria indicated that all research institutions in their
respective countries were required to adopt a policy re-
garding research ethics.
Functions, criteria for NEC membership, and compos-
ition: The question “what are the main functions of the
national ethics review committee?” elicited a variety of
responses. Only those responses commonly observed are
reported here. They include ensuring ethical principles
are observed in health research, including research on
vulnerable groups and socially sensitive conditions such
as HIV/AIDS; reviewing clinical trials; reviewing PhD
study proposals; reviewing externally funded projects;
approving agreements on biological sample and data
transfer; providing policy advice to the ministry of health
on health related research; conducting scientific review;
undertaking regular capacity building for members; and
monitoring ongoing approved studies. The Kenyan NEC
was unique in that it does not review research proposals;
its functions are to review national health research ethics
guidelines, formulate policy, act as policy adviser to the
ministry of health, arbitration and accreditation of insti-
tutional ERCs.
Some NECs in the Region perform the dual function
of scientific and ethics review. This dual functionality is
not surprising because scientifically unsound research is
unethical. It could also be because of the overarching
oversight function of NECs that these functions are
vested under one entity. It is also noteworthy to observe
that some NECs play the role of providing policy advice
to the ministry of health. This can be potentially worri-
some especially when questions of a NEC’s independ-
ence arise.
On the criteria of NEC membership, the study made
an enquiry of how NECs were constituted by asking “are
their written guidelines for constituting (i.e. selection of
members) the national ethics review committee?” About
83.9 % NECs had written guidelines for selecting
members. All NECs indicated that their composition
was multidisciplinary in nature; however some skill sets
such as those of non-physician health research profes-
sionals (namely statisticians, biomedical scientists and
epidemiologists); physicians and lawyers were more rep-
resented than others. All NECs (100 %) had more than
one member who was non-physician health research
professional, 93.6 % of NECs had physicians, and 81.3 %
had lawyers. About 56.3 % NECs had religious leaders
and community representatives respectively. Only 34.4 %
of the respondent NECs had members who were
ethicists, pointing to a continued shortage of profes-
sionals formally trained in health research ethics in the
Region. The gaps from the scarcity of these and other
skills is possibly addressed by engaging experts or con-
sultants from time to time. To this end it is instructive
to note that about 76.7 % of the NECs indicated that
they periodically engage consultants for technical sup-
port. In response to the question “What in your opinion
could be done to improve the performance of the national
ethics committee”, 26.7 % of NECS indicated that they
needed to review policies guiding NEC membership to
update the composition of the committee and make it in-
clusive of diverse skill-sets, and replace inactive members.
About 21.9 % NECs had representatives from patient
advocacy groups, and 15.6 % had representatives from
media. About 9.4 % NECs had members who were trad-
itional practitioners, regulatory officers, representatives
of professional associations respectively. This indicates a
sub-optimal level of involvement of these constituencies.
b. Existence of mechanisms for ethical review of health
research
All countries with NEC, except Ethiopia and Burundi,
indicated that their NECs had written standard operating
procedures (SOPs) for the conduct of business including
clear guidelines for decision-making and managing sce-
narios of conflict of interest among Committee members.
Those NECs with SOPs had established research proposal
submission guidelines detailing required documents to be
submitted with the research protocol. For most NECs the
necessary accompanying documents included a brief sum-
mary of the research protocol, data collection instruments
(case report forms and questionnaires), safety, pharmaco-
logical and toxicological data on the product being investi-
gated, participant recruitment material and description of
procedures for obtaining and documenting informed
consent, principal investigator’s CV and documents of
approval from other ethics review committees or regula-
tory agencies. Some NECs had additional requirements
for example Nigeria required evidence of training in re-
search ethics, Zambia required biological transfer agree-
ments to be presented, and Gabon required evidence of
insurance coverage for research participants. This finding
further supports the assertion above linking average NEC
ages to maturity, that NECs in the Region can indeed be
assumed to have reached maturity and have established
procedures for conducting ethical review. It must however
be noted that maturity levels and experiences of NECs
may differ from country to country.
Monitoring on-going research and penalties for non-
compliance with ethical standards: About 76.7 % of
respondent NECs reported to have mechanisms for
monitoring on-going research. The most commonly
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applied mechanisms included a requirement for the
submission of periodic written reports by the principle
investigator (PI), unannounced audit/site visits by NEC
representatives, and annual ethical review of previously
approved projects. Incidentally, some NECs that had re-
search monitoring mechanisms in place did not have a
penalty system for non-compliance with relevant regula-
tions and NEC decisions. Only 65.6 % of respondent
NECs stated that they instituted penalties for non-
compliance. The most common penalty was suspension
of research (100 %); reporting to national regulatory
authorities (71.4 %); and withdrawal of funds (19.1 %).
Another less cited penalty was withdrawal of ethics
approval renewal.
c. Continuous ethics training and capacity
requirements
A number of capacity building initiatives [15, 16] for
health research ethics have been put in place over time.
However, there still remain capacity (both human and
infrastructural) challenges in the Region. It was earlier
stated that the Region faces a shortage of professionally
trained ethicists and that NECS tend to have an over-
representation of some skills. This, together with the
rapidly evolving nature of health research due to
scientific and technological advancements and emerging
epidemics, calls for a concerted effort towards strength-
ening NECs capacities.
About 50 % of respondent NECs indicated that
undergoing training was a requirement for committee
members. About 66.7 % NECs indicated that capacity
building opportunities were made available to committee
members. This therefore means that there are some
NECs who do not ensure that their members receive any
training. Table 3 below summarizes the most commonly
observed responses given to the question “What in your
view are the specific capacity needs of the national ethics
committee?”
Most NECs (66.3 %) indicated that they need periodic
training on international guidelines for health research
ethics. Periodic training provides an opportunity for com-
mittee members to update and refresh their knowledge on
ethical values, concepts, and relevant international norma-
tive documents guiding health research ethics. Periodic
training also allows NECs to stay abreast with contempor-
ary ethical issues such as effective engagement with com-
munities, risk and benefit analysis and determination,
approached to obtaining voluntary informed consent, and
equitable research benefits sharing. Periodic training be-
comes an important capacity strengthening avenue for
NECs in the African Region where members have other
full-time jobs and only serve on the NEC as an additional
professional responsibility.
The second most common capacity need emerging from
the survey, and indicated by 53.3 % of the NECS, was
training on evaluating clinical trials. This comes as no sur-
prise since the Region is experiencing an influx of clinical
trials, particularly vaccine trials. About 16.7 % of the NECs
indicated that they needed capacity for accrediting and fi-
nancing institutional ethics review committees. This can
be used as a good proxy indicator for maturity. Those
NECs, such as Tanzania and Uganda, desirous of develop-
ing an accreditation framework and criteria for institu-
tional ethics review committees can be construed to have
attained a high level of functional and capacity maturity
and are ready for the next phase of building other ERC’s
capacities. About 16.7 % NECS indicated that they needed
to strengthen their capacities for continuous review, over-
sight, auditing, monitoring and evaluation. About 13.3 %
needed to capacities to improve their database manage-
ment (filing and archiving) systems.
About 83.3 % NECs indicated that they had secretarial
and administrative support. However, 50 % of the NECs
indicated that they needed funds specifically allocated for
the operations of the committee. The most commonly
cited areas where funds would be used included enhan-
cing health research monitoring activities, providing op-
portunities for members to attend international
conferences and seminars, providing cash incentives for
NEC members, conducting public awareness and commu-
nity sensitization activities, and subscription to bioethics
journals. This indicates that most NECs in the Region are
not adequately funded.
Suggestions for further research
This study provides a broad overview of the readiness of
ethics review systems for a changing public health land-
scape in the WHO African Region. It provides basic in-
formation and data, which can be further interrogated
through research, on the status of NECs as assessed
against three inter-dependent themes namely, govern-
ance of health research; existence of mechanisms for
Table 3 Capacity needs of NECs in the African Region
Capacity need Observations (%)
Periodic training on international guidelines for
health research ethics and bioethics generally
66.3 %
Training on evaluating clinical trials 53.3 %
Allocation of funds for the work of NEC
(administrative and secretariat support)
50 %
Capacity for setting up and accrediting institutional
ethics review committees including supporting
them financially
16.7 %
Strengthening continuous review, oversight,
auditing, monitoring and evaluation capacities
16.7 %
Database management – documentation and
archiving of research protocols
13.3 %
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ethical review of health research; and continuous ethics
training and capacity requirements. Research to confirm
anecdotal observations pointing to operational inde-
pendence and maturity of NECs is one area that could
be further explored.
Another possible strand for future policy research would
be to identify factors, interests and mechanisms that will
galvanize all health research stakeholders in the Region in-
cluding governments and medical research councils;
schools of public health and medicine; regional and na-
tional public health associations; the African Union,
United Nations’ agencies and intergovernmental organiza-
tions; and industry to support formation and strengthen-
ing of NECs in the Region.
Conclusions
The findings of this survey lead us to make a number of
observations and policy recommendations. The finding on
the presence of a possible legal lacuna for the operations
of most NECs supports an argument that has been made
before by Chima [1] on the need for the regional guide-
lines on health research drawn by a body such as the Afri-
can Union, similar to the EU directives [17]. The
guidelines would provide guidance on a number of issues,
such as defining the standard of care; the use of placebo-
controlled trials; process of obtaining voluntary informed
consent in a community context; and community engage-
ment. Such guidelines would take into account regional
contextual specificities, and would be adapted by coun-
tries of the region into legislation.
It is clear that different NECs are at different stages of
maturity, with some having a broader experience-base to
draw from and others much less. While continued ef-
forts by countries must be made to further strengthen
human and infrastructural capacities, the fast evolving
global public health landscape, such as testing inves-
tigational products for the Ebola virus disease would
warrant proposing the creation of a regional platform/
network, whose membership would be open to all NECs
of the Region, to offer an opportunity for expeditiously
and effectively addressing the challenge posed by weak
and in some cases non-existent human resource capaci-
ties. Such a regional entity would serve to provide a
forum for collaboration, networking and information
sharing among NECs, would encourage harmonization
of health research ethics policies and practices and pro-
cedures in countries of the Region, and would facilitate
joint reviews especially when countries receive similar
research proposals from one research group.
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